{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T03:13:56Z","timestamp":1793157236931,"version":"4.5.0"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,10,21]],"date-time":"2022-10-21T00:00:00Z","timestamp":1666310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,10,21]],"date-time":"2022-10-21T00:00:00Z","timestamp":1666310400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Mucin-type-O-glycosylation on proteins is integrally involved in human health and disease and is coordinated by an enzyme family of 20<jats:italic>N<\/jats:italic>-acetylgalactosaminyltransferases (GalNAc-Ts). Detailed knowledge on the biological effects of site-specific O-glycosylation is limited due to lack of information on specific glycosylation enzyme activities and O-glycosylation site-occupancies. Here we present a systematic analysis of the isoform-specific targets of all GalNAc-Ts expressed within a tissue-forming human skin cell line, and demonstrate biologically significant effects of O-glycan initiation on epithelial formation. We find over 300 unique glycosylation sites across a diverse set of proteins specifically regulated by one of the GalNAc-T isoforms, consistent with their impact on the tissue phenotypes. Notably, we discover a high variability in the O-glycosylation site-occupancy of 70 glycosylated regions of secreted proteins. These findings revisit the relevance of individual O-glycosylation sites in the proteome, and provide an approach to establish which sites drive biological functions.<\/jats:p>","DOI":"10.1038\/s41467-022-33806-8","type":"journal-article","created":{"date-parts":[[2022,10,21]],"date-time":"2022-10-21T12:06:04Z","timestamp":1666353964000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":41,"title":["Global mapping of GalNAc-T isoform-specificities and O-glycosylation site-occupancy in a tissue-forming human cell line"],"prefix":"10.1038","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6823-5354","authenticated-orcid":false,"given":"Mathias I.","family":"Nielsen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noortje","family":"de Haan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weston","family":"Kightlinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8829-6579","authenticated-orcid":false,"given":"Zilu","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sally","family":"Dabelsteen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minyan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2948-6211","authenticated-orcid":false,"given":"Michael C.","family":"Jewett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9383-8448","authenticated-orcid":false,"given":"Ieva","family":"Bagdonaite","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0418-5765","authenticated-orcid":false,"given":"Sergey Y.","family":"Vakhrushev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0240-9232","authenticated-orcid":false,"given":"Hans H.","family":"Wandall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,10,21]]},"reference":[{"key":"33806_CR1","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1093\/glycob\/cww086","volume":"27","author":"A Varki","year":"2017","unstructured":"Varki, A. Biological roles of glycans. Glycobiology 27, 3\u201349 (2017).","journal-title":"Glycobiology"},{"key":"33806_CR2","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1038\/s41580-020-00294-x","volume":"21","author":"KT Shjoldager","year":"2020","unstructured":"Shjoldager, K. T., Narimatsu, Y., Joshi, H. J. & Clausen, H. Global view of human protein glycosylation pathways and functions. Nat. Rev. Mol. Cell Biol. 21, 729\u2013749 (2020).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"33806_CR3","doi-asserted-by":"publisher","first-page":"7183","DOI":"10.1111\/febs.16148","volume":"288","author":"HH Wandall","year":"2021","unstructured":"Wandall, H. H., Nielsen, M. A. I., King-Smith, S., de Haan, N. & Bagdonaite, I. Global functions of O-glycosylation: promises and challenges in O-glycobiology. FEBS J. 288, 7183\u20137212 (2021).","journal-title":"FEBS J."},{"key":"33806_CR4","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1093\/glycob\/cwr182","volume":"22","author":"EP Bennett","year":"2012","unstructured":"Bennett, E. P. et al. Control of mucin-type O-glycosylation: a classification of the polypeptide GalNAc-transferase gene family. Glycobiology 22, 736\u2013756 (2012).","journal-title":"Glycobiology"},{"key":"33806_CR5","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.sbi.2018.12.007","volume":"56","author":"M de las Rivas","year":"2019","unstructured":"de las Rivas, M., Lira-Navarrete, E., Gerken, T. A. & Hurtado-Guerrero, R. Polypeptide GalNAc-Ts: from redundancy to specificity. Curr. Opin. Struct. Biol. 56, 87\u201396 (2019).","journal-title":"Curr. Opin. Struct. Biol."},{"key":"33806_CR6","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1038\/emboj.2013.79","volume":"32","author":"C Steentoft","year":"2013","unstructured":"Steentoft, C. et al. Precision mapping of the human O-GalNAc glycoproteome through SimpleCell technology. EMBO J. 32, 1478\u20131488 (2013).","journal-title":"EMBO J."},{"key":"33806_CR7","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1182\/bloodadvances.2016002121","volume":"1","author":"SL King","year":"2017","unstructured":"King, S. L. et al. Characterizing the O-glycosylation landscape of human plasma, platelets, and endothelial cells. Blood Adv. 1, 429\u2013442 (2017).","journal-title":"Blood Adv."},{"key":"33806_CR8","doi-asserted-by":"publisher","first-page":"e8486","DOI":"10.15252\/msb.20188486","volume":"14","author":"W Yang","year":"2018","unstructured":"Yang, W., Ao, M., Hu, Y., Li, Q. K. & Zhang, H. Mapping the O-glycoproteome using site-specific extraction of O-linked glycopeptides (EXoO). Mol. Syst. Biol. 14, e8486 (2018).","journal-title":"Mol. Syst. Biol."},{"key":"33806_CR9","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1038\/nmeth.3366","volume":"12","author":"CM Woo","year":"2015","unstructured":"Woo, C. M., Iavarone, A. T., Spiciarich, D. R., Palaniappan, K. K. & Bertozzi, C. R. Isotope-targeted glycoproteomics (IsoTaG): A mass-independent platform for intact N- and O-glycopeptide discovery and analysis. Nat. Methods 12, 561\u2013567 (2015).","journal-title":"Nat. Methods"},{"key":"33806_CR10","doi-asserted-by":"publisher","first-page":"14623","DOI":"10.1073\/pnas.1511175112","volume":"112","author":"CK Goth","year":"2015","unstructured":"Goth, C. K. et al. A systematic study of modulation of ADAM-mediated ectodomain shedding by site-specific O-glycosylation. Proc. Natl Acad. Sci. USA 112, 14623\u201314628 (2015).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"33806_CR11","doi-asserted-by":"publisher","first-page":"7408","DOI":"10.1074\/jbc.M117.817981","volume":"293","author":"S Wang","year":"2018","unstructured":"Wang, S. et al. Site-specific O-glycosylation of members of the low-density lipoprotein receptor superfamily enhances ligand interactions. J. Biol. Chem. 293, 7408\u20137422 (2018).","journal-title":"J. Biol. Chem."},{"key":"33806_CR12","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1038\/ng1358","volume":"36","author":"O Topaz","year":"2004","unstructured":"Topaz, O. et al. Mutations in GALNT3, encoding a protein involved in O-linked glycosylation, cause familial tumoral calcinosis. Nat. Genet. 36, 579\u2013581 (2004).","journal-title":"Nat. Genet."},{"key":"33806_CR13","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.bbadis.2008.09.016","volume":"1792","author":"I Chefetz","year":"2009","unstructured":"Chefetz, I. et al. GALNT3, a gene associated with hyperphosphatemic familial tumoral calcinosis, is transcriptionally regulated by extracellular phosphate and modulates matrix metalloproteinase activity. Biochim. Biophys. Acta. Mol. Basis. Dis. 1792, 61\u201367 (2009).","journal-title":"Biochim. Biophys. Acta. Mol. Basis. Dis."},{"key":"33806_CR14","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1007\/s12020-015-0705-8","volume":"53","author":"A Marucci","year":"2016","unstructured":"Marucci, A., Mangiacotti, D., Trischitta, V. & di Paola, R. GALNT2 mRNA levels are associated with serum triglycerides in humans. Endocrine 53, 331\u2013334 (2016).","journal-title":"Endocrine"},{"key":"33806_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/srep19079","volume":"6","author":"T Guo","year":"2016","unstructured":"Guo, T. et al. Association between the DOCK7, PCSK9 and GALNT2 gene polymorphisms and serum lipid levels. Sci. Rep. 6, 19079 (2016).","journal-title":"Sci. Rep."},{"key":"33806_CR16","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.cmet.2016.07.012","volume":"24","author":"SA Khetarpal","year":"2016","unstructured":"Khetarpal, S. A. et al. Loss of function of GALNT2 lowers high-density lipoproteins in humans, nonhuman primates, and rodents. Cell Metab. 24, 234\u2013245 (2016).","journal-title":"Cell Metab."},{"key":"33806_CR17","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/j.cmet.2011.11.005","volume":"14","author":"AG Holleboom","year":"2011","unstructured":"Holleboom, A. G. et al. Heterozygosity for a loss-of-function mutation in GALNT2 improves plasma triglyceride clearance in man. Cell Metab. 14, 811\u2013818 (2011).","journal-title":"Cell Metab."},{"key":"33806_CR18","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.sbi.2020.12.010","volume":"68","author":"T \u010caval","year":"2021","unstructured":"\u010caval, T., de Haan, N., Konstantinidi, A. & Vakhrushev, S. Y. Quantitative characterization of O-GalNAc glycosylation. Curr. Opin. Struct. Biol. 68, 135\u2013141 (2021).","journal-title":"Curr. Opin. Struct. Biol."},{"key":"33806_CR19","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/j.devcel.2020.06.039","volume":"54","author":"S Dabelsteen","year":"2020","unstructured":"Dabelsteen, S. et al. Essential functions of glycans in human epithelia dissected by a CRISPR-Cas9-engineered human organotypic skin model. Dev. Cell 54, 669\u2013684.e7 (2020).","journal-title":"Dev. Cell"},{"key":"33806_CR20","doi-asserted-by":"publisher","first-page":"E4066","DOI":"10.1073\/pnas.1406619111","volume":"111","author":"P Radhakrishnan","year":"2014","unstructured":"Radhakrishnan, P. et al. Immature truncated O-glycophenotype of cancer directly induces oncogenic features. Proc. Natl Acad. Sci. USA 111, E4066\u2013E4075 (2014).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"33806_CR21","doi-asserted-by":"publisher","first-page":"e59","DOI":"10.1093\/nar\/gkv126","volume":"43","author":"Z Yang","year":"2015","unstructured":"Yang, Z. et al. Fast and sensitive detection of indels induced by precise gene targeting. Nucleic Acids Res. 43, e59\u2013e59 (2015).","journal-title":"Nucleic Acids Res."},{"key":"33806_CR22","first-page":"1298","volume":"6","author":"K Lavrsen","year":"2017","unstructured":"Lavrsen, K. et al. De novo expression of human polypeptide N-acetylgalactosaminyltransferase 6 (GalNAc-T6) in colon adenocarcinoma inhibits the differentiation of colonic epithelium. J. Biol. Chem. 6, 1298\u20131314 (2017).","journal-title":"J. Biol. Chem."},{"key":"33806_CR23","doi-asserted-by":"publisher","first-page":"11167","DOI":"10.1021\/acs.analchem.1c01696","volume":"93","author":"Y Mao","year":"2021","unstructured":"Mao, Y. et al. Systematic evaluation of fragmentation methods for unlabeled and isobaric mass tag-labeled O-glycopeptides. Anal. Chem. 93, 11167\u201311175 (2021).","journal-title":"Anal. Chem."},{"key":"33806_CR24","unstructured":"Joshi, H. J. et al. Glycoscience: Biology and Medicine (eds Endo, T., Seeberger, P. H., Hart G. W., Wong, C.-H. & Taniguchi, N.) p. 1\u201314 (Springer, 2014)."},{"key":"33806_CR25","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/0968-0004(90)90014-3","volume":"15","author":"N Jentoft","year":"1990","unstructured":"Jentoft, N. Why are proteins O-glycosylated? Trends Biochem. Sci. 15, 291\u2013294 (1990).","journal-title":"Trends Biochem. Sci."},{"key":"33806_CR26","doi-asserted-by":"publisher","first-page":"D480","DOI":"10.1093\/nar\/gkaa1100","volume":"49","author":"A Bateman","year":"2021","unstructured":"Bateman, A. et al. UniProt: the universal protein knowledgebase in 2021. Nucleic Acids Res. 49, D480\u2013D489 (2021).","journal-title":"Nucleic Acids Res."},{"key":"33806_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/glycob\/cwg007","volume":"13","author":"KG ten Hagen","year":"2003","unstructured":"ten Hagen, K. G., Fritz, T. A. & Tabak, L. A. All in the family: The UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferases. Glycobiology 13, 1\u201316 (2003).","journal-title":"Glycobiology"},{"key":"33806_CR28","doi-asserted-by":"publisher","first-page":"17312","DOI":"10.1074\/jbc.M113.545053","volume":"289","author":"NB Pedersen","year":"2014","unstructured":"Pedersen, N. B. et al. Low density lipoprotein receptor class A repeats are O-glycosylated in linker regions. J. Biol. Chem. 289, 17312\u201317324 (2014).","journal-title":"J. Biol. Chem."},{"key":"33806_CR29","doi-asserted-by":"publisher","first-page":"e48885","DOI":"10.15252\/embr.201948885","volume":"21","author":"I Bagdonaite","year":"2020","unstructured":"Bagdonaite, I. et al. O-glycan initiation directs distinct biological pathways and controls epithelial differentiation. EMBO Rep. 21, e48885 (2020).","journal-title":"EMBO Rep."},{"key":"33806_CR30","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.15252\/embr.201540796","volume":"16","author":"KT Schjoldager","year":"2015","unstructured":"Schjoldager, K. T. et al. Deconstruction of O-glycosylation\u2013GalNAc-T isoforms direct distinct subsets of the O-glycoproteome. EMBO Rep. 16, 1713\u20131722 (2015).","journal-title":"EMBO Rep."},{"key":"33806_CR31","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1074\/mcp.RA118.001121","volume":"18","author":"Y Narimatsu","year":"2019","unstructured":"Narimatsu, Y. et al. Exploring regulation of protein O-glycosylation in isogenic human HEK293 cells by differential O-glycoproteomics. Mol. Cell. Proteom. 18, 1396\u20131409 (2019).","journal-title":"Mol. Cell. Proteom."},{"key":"33806_CR32","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1038\/nature09270","volume":"466","author":"TM Teslovich","year":"2010","unstructured":"Teslovich, T. M. et al. Biological, clinical and population relevance of 95 loci for blood lipids. Nature 466, 707\u2013713 (2010).","journal-title":"Nature"},{"key":"33806_CR33","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1038\/ng.76","volume":"40","author":"CJ Willer","year":"2008","unstructured":"Willer, C. J. et al. Newly identified loci that influence lipid concentrations and risk of coronary artery disease. Nat. Genet. 40, 161\u2013169 (2008).","journal-title":"Nat. Genet."},{"key":"33806_CR34","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1002\/jms.3210","volume":"48","author":"K Stavenhagen","year":"2013","unstructured":"Stavenhagen, K. et al. Quantitative mapping of glycoprotein micro-heterogeneity and macro-heterogeneity: an evaluation of mass spectrometry signal strengths using synthetic peptides and glycopeptides. J. Mass Spectrom. 48, 627\u2013639 (2013).","journal-title":"J. Mass Spectrom."},{"key":"33806_CR35","doi-asserted-by":"publisher","first-page":"4343","DOI":"10.1021\/acs.analchem.1c05068","volume":"94","author":"N de Haan","year":"2022","unstructured":"de Haan, N. et al. In-depth profiling of O-glycan isomers in human cells using C18 nanoliquid chromatography-mass spectrometry and glycogenomics. Anal. Chem. 94, 4343\u20134351 (2022).","journal-title":"Anal. Chem."},{"key":"33806_CR36","doi-asserted-by":"publisher","first-page":"2589","DOI":"10.1038\/s41596-020-0345-1","volume":"15","author":"W Yang","year":"2020","unstructured":"Yang, W., Song, A., Ao, M., Xu, Y. & Zhang, H. Large-scale site-specific mapping of the O-GalNAc glycoproteome. Nat. Protoc. 15, 2589\u20132610 (2020).","journal-title":"Nat. Protoc."},{"key":"33806_CR37","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.1021\/acs.jproteome.6b01053","volume":"16","author":"CM Woo","year":"2017","unstructured":"Woo, C. M. et al. Development of IsoTaG, a chemical glycoproteomics technique for profiling intact N- and O-glycopeptides from whole cell proteomes. J. Proteome Res. 16, 1706\u20131718 (2017).","journal-title":"J. Proteome Res."},{"key":"33806_CR38","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1038\/nrc2761","volume":"9","author":"DW Kufe","year":"2009","unstructured":"Kufe, D. W. Mucins in cancer: function, prognosis and therapy. Nat. Rev. Cancer 9, 874\u2013885 (2009).","journal-title":"Nat. Rev. Cancer"},{"key":"33806_CR39","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1146\/annurev-biochem-011520-105053","volume":"89","author":"GC Hansson","year":"2020","unstructured":"Hansson, G. C. Mucins and the microbiome. Annu Rev. Biochem. 89, 769\u2013793 (2020).","journal-title":"Annu Rev. Biochem."},{"key":"33806_CR40","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-31062-4","volume":"13","author":"SA Malaker","year":"2022","unstructured":"Malaker, S. A. et al. Revealing the human mucinome. Nat. Commun. 13, 3542 (2022).","journal-title":"Nat. Commun."},{"key":"33806_CR41","doi-asserted-by":"publisher","first-page":"7278","DOI":"10.1073\/pnas.1813020116","volume":"116","author":"SA Malaker","year":"2019","unstructured":"Malaker, S. A. et al. The mucin-selective protease StcE enables molecular and functional analysis of human cancer-associated mucins. Proc. Natl Acad. Sci. USA 116, 7278\u20137287 (2019).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"33806_CR42","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1074\/jbc.M510754200","volume":"281","author":"B Xie","year":"2006","unstructured":"Xie, B. et al. Identification of the fibroblast growth factor (FGF)-interacting domain in a secreted FGF-binding protein by phage display. J. Biol. Chem. 281, 1137\u20131144 (2006).","journal-title":"J. Biol. Chem."},{"key":"33806_CR43","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1002\/pro.5560040716","volume":"4","author":"P Bork","year":"1995","unstructured":"Bork, P. & Patthy, L. The SEA module: a new extracellular domain associated with O-glycosylation. Protein Sci. 4, 1421\u20131425 (1995).","journal-title":"Protein Sci."},{"key":"33806_CR44","doi-asserted-by":"publisher","first-page":"19064","DOI":"10.1074\/jbc.RA118.004516","volume":"293","author":"J Hintze","year":"2018","unstructured":"Hintze, J. et al. Probing the contribution of individual polypeptide GalNAc-transferase isoforms to the O -glycoproteome by inducible expression in isogenic cell lines. J. Biol. Chem. 293, 19064\u201319077 (2018).","journal-title":"J. Biol. Chem."},{"key":"33806_CR45","doi-asserted-by":"crossref","first-page":"3997","DOI":"10.1242\/jcs.175539","volume":"128","author":"EK Duperret","year":"2015","unstructured":"Duperret, E. K., Dahal, A. & Ridky, T. W. Focal-adhesion-independent integrin-av regulation of FAK and c-Myc is necessary for 3D skin formation and tumor invasion. J. Cell Sci. 128, 3997\u20134013 (2015).","journal-title":"J. Cell Sci."},{"key":"33806_CR46","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1038\/sj.jid.5701231","volume":"128","author":"S Sercu","year":"2008","unstructured":"Sercu, S. et al. Interaction of extracellular matrix protein 1 with extracellular matrix components: ECM1 is a basement membrane protein of the skin. J. Investig. Dermatol. 128, 1397\u20131408 (2008).","journal-title":"J. Investig. Dermatol."},{"key":"33806_CR47","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1038\/ng.145","volume":"40","author":"SA Fisher","year":"2008","unstructured":"Fisher, S. A. et al. Genetic determinants of ulcerative colitis include the ECM1 locus and five loci implicated in Crohn\u2019s disease. Nat. Genet. 40, 710\u2013712 (2008).","journal-title":"Nat. Genet."},{"key":"33806_CR48","doi-asserted-by":"crossref","unstructured":"Tian, E. et al. Galnt11 regulates kidney function by glycosylating the endocytosis receptor megalin to modulate ligand binding. Proc. Natl Acad. Sci. USA 116, 25196\u201325202. (2019).","DOI":"10.1073\/pnas.1909573116"},{"key":"33806_CR49","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1093\/glycob\/cwr179","volume":"22","author":"X Li","year":"2012","unstructured":"Li, X. et al. Characterization of ppGalNAc-T18, a member of the vertebrate-specific y subfamily of UDP-N-acetyl-d-galactosamine:polypeptide N- acetylgalactosaminyltransferases. Glycobiology 22, 602\u2013615 (2012).","journal-title":"Glycobiology"},{"key":"33806_CR50","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1016\/j.bbagen.2019.01.009","volume":"1863","author":"A Shan","year":"2019","unstructured":"Shan, A. et al. Polypeptide N-acetylgalactosaminyltransferase 18 non-catalytically regulates the ER homeostasis and O-glycosylation. Biochimica et. Biophysica Acta - Gen. Subj. 1863, 870\u2013882 (2019).","journal-title":"Biochimica et. Biophysica Acta - Gen. Subj."},{"key":"33806_CR51","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1016\/j.molcel.2020.03.030","volume":"78","author":"B Schumann","year":"2020","unstructured":"Schumann, B. et al. Bump-and-Hole Engineering Identifies Specific Substrates of Glycosyltransferases in Living Cells. Mol. Cell 78, 824\u2013834.e15 (2020).","journal-title":"Mol. Cell"},{"key":"33806_CR52","doi-asserted-by":"crossref","unstructured":"Yadati, T., Houben, T., Bitorina, A. & Shiri-Sverdlov, R. The Ins and Outs of Cathepsins: Physiological Function and Role in Disease Management. Cells 9 (2020).","DOI":"10.3390\/cells9071679"},{"key":"33806_CR53","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1172\/JCI16306","volume":"111","author":"T Ishida","year":"2003","unstructured":"Ishida, T. et al. Endothelial lipase is a major determinant of HDL level. J. Clin. Investig. 111, 347\u2013355 (2003).","journal-title":"J. Clin. Investig."},{"key":"33806_CR54","first-page":"1042","volume":"119","author":"AC Edmondson","year":"2009","unstructured":"Edmondson, A. C. et al. Loss-of-function variants in endothelial lipase are a cause of elevated HDL cholesterol in humans. J. Clin. Investig. 119, 1042\u20131050 (2009).","journal-title":"J. Clin. Investig."},{"key":"33806_CR55","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1126\/scitranslmed.abb0602","volume":"13","author":"JE le Lay","year":"2021","unstructured":"le Lay, J. E. et al. Blocking endothelial lipase with monoclonal antibody MEDI5884 durably increases high density lipoprotein in nonhuman primates and in a phase 1 trial. Sci. Transl. Med. 13, 16\u201318 (2021).","journal-title":"Sci. Transl. Med"},{"key":"33806_CR56","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1016\/j.ajhg.2015.10.016","volume":"97","author":"TS Roman","year":"2015","unstructured":"Roman, T. S. et al. Multiple Hepatic Regulatory Variants at the GALNT2 GWAS Locus Associated with High-Density Lipoprotein Cholesterol. Am. J. Hum. Genet. 97, 801\u2013815 (2015).","journal-title":"Am. J. Hum. Genet."},{"key":"33806_CR57","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1038\/ng.75","volume":"40","author":"S Kathiresan","year":"2008","unstructured":"Kathiresan, S. et al. Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans. Nat. Genet. 40, 189\u2013197 (2008).","journal-title":"Nat. Genet."},{"key":"33806_CR58","doi-asserted-by":"publisher","first-page":"22942","DOI":"10.1074\/jbc.M803387200","volume":"283","author":"J Raman","year":"2008","unstructured":"Raman, J. et al. The catalytic and lectin domains of UDP-GalNAc:polypeptide \u03b1-N-acetylgalactosaminyltransferase function in concert to direct glycosylation site selection. J. Biol. Chem. 283, 22942\u201322951 (2008).","journal-title":"J. Biol. Chem."},{"key":"33806_CR59","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1093\/glycob\/cwv108","volume":"26","author":"L Revoredo","year":"2016","unstructured":"Revoredo, L. et al. Mucin-type o-glycosylation is controlled by short- And long-range glycopeptide substrate recognition that varies among members of the polypeptide GalNAc transferase family. Glycobiology 26, 360\u2013376 (2016).","journal-title":"Glycobiology"},{"key":"33806_CR60","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1042\/BCJ20200607","volume":"478","author":"DJ Shon","year":"2021","unstructured":"Shon, D. J., Kuo, A., Ferracane, M. J. & Malaker, S. A. Classification, structural biology, and applications of mucin domain-targeting proteases. Biochemical J. 478, 1585\u20131603 (2021).","journal-title":"Biochemical J."},{"key":"33806_CR61","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1128\/MCB.20.4.1436-1447.2000","volume":"20","author":"MA Dickson","year":"2000","unstructured":"Dickson, M. A. et al. Human keratinocytes that express hTERT and also bypass a p16(INK4a)-enforced mechanism that limits life span become immortal yet retain normal growth and differentiation characteristics. Mol. Cell Biol. 20, 1436\u20131447 (2000).","journal-title":"Mol. Cell Biol."},{"key":"33806_CR62","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1093\/glycob\/cwx101","volume":"28","author":"Y Narimatsu","year":"2018","unstructured":"Narimatsu, Y. et al. A validated gRNA library for CRISPR\/Cas9 targeting of the human glycosyltransferase genome. Glycobiology 28, 295\u2013305 (2018).","journal-title":"Glycobiology"},{"key":"33806_CR63","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1038\/nbt.3437","volume":"34","author":"JG Doench","year":"2016","unstructured":"Doench, J. G. et al. Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9. Nat. Biotechnol. 34, 184\u2013191 (2016).","journal-title":"Nat. Biotechnol."},{"key":"33806_CR64","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1038\/nmeth.3047","volume":"11","author":"NE Sanjana","year":"2014","unstructured":"Sanjana, N. E., Shalem, O. & Zhang, F. Improved vectors and genome-wide libraries for CRISPR screening. Nat. Methods 11, 783\u2013784 (2014).","journal-title":"Nat. Methods"},{"key":"33806_CR65","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1002\/stem.64","volume":"27","author":"S Dabelsteen","year":"2009","unstructured":"Dabelsteen, S. et al. Epithelial cells derived from human embryonic stem cells display P16 INK4A senescence, hypermotility, and differentiation properties shared by many P63+ somatic cell types. Stem Cells 27, 1388\u20131399 (2009).","journal-title":"Stem Cells"},{"key":"33806_CR66","doi-asserted-by":"crossref","unstructured":"Marinova, I. N., Wandall, H. H. & Dabelsteen, S. Protocol for CRISPR-Cas9 modification of glycosylation in 3D organotypic skin models. STAR Protocols 2, (2021).","DOI":"10.1016\/j.xpro.2021.100668"},{"key":"33806_CR67","doi-asserted-by":"publisher","first-page":"D543","DOI":"10.1093\/nar\/gkab1038","volume":"50","author":"Y Perez-Riverol","year":"2022","unstructured":"Perez-Riverol, Y. et al. The PRIDE database resources in 2022: A hub for mass spectrometry-based proteomics evidences. Nucleic Acids Res. 50, D543\u2013D552 (2022).","journal-title":"Nucleic Acids Res."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-33806-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-33806-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-33806-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,6]],"date-time":"2024-10-06T08:52:53Z","timestamp":1728204773000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-33806-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,21]]},"references-count":67,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["33806"],"URL":"https:\/\/doi.org\/10.1038\/s41467-022-33806-8","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,21]]},"assertion":[{"value":"4 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare the following competing financial interests: H.H.W. owns stocks and is a consultant for and co-founder of EbuMab, ApS, Hemab, ApS, and GO- Therapeutics, Inc., all not involved in, or related to, the research performed in this study. All other authors declare no conflicts of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"6257"}}